Literature DB >> 18368636

Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.

N Malila1, T Oivanen, M Hakama.   

Abstract

BACKGROUND AND STUDY AIMS: Colorectal cancer mortality can be reduced by repeated screening, using faecal occult blood testing. This report describes the implementation of service screening in Finland and performance indicators from the first three years.
METHODS: The programme is based on gradual expansion over six years of implementation. It involves individual-level randomisation into screening or control arms among a target population of men and women aged 60-69 years. The effects will be evaluated comparing incidence of and mortality from colorectal cancer in the invited arm with the controls. The screening test is a biannual guaiac-based faecal occult blood test with three test cards for consecutive samples and colonoscopies offered to those with any blood observed.
RESULTS: Between September 2004 and December 2006, 52,994 test kits (to 26,247 men and 26,747 women) were sent out in 160 municipalities out of 444. Attendance to screening was 71% overall, 63% in men and 78% in women. People from the youngest age-group (born in 1946) were less compliant than those from the oldest one (born in 1940). Among the screened, 2.1% were found with blood in the stools, 3% of men and 1.5% of women. Cancers and adenomas were detected according to expectations, in 8.6 and 43.2%, respectively, among those who underwent colonoscopy.
CONCLUSIONS: The implementation measured with attendance and performance of the test of colorectal cancer screening in Finland has been successful. The programme meets the criteria both for a randomised trial and for a public health programme allowing unbiased data to be collected during the implementation period.

Entities:  

Mesh:

Year:  2008        PMID: 18368636     DOI: 10.1055/s-2007-963490

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  7 in total

1.  Sociodemographic predictors of participation in colorectal cancer screening.

Authors:  Ulrik Deding; Anna Sharon Henig; Ann Salling; Christian Torp-Pedersen; Henrik Bøggild
Journal:  Int J Colorectal Dis       Date:  2017-05-13       Impact factor: 2.571

Review 2.  Serum tests for colorectal cancer screening.

Authors:  James Creeden; Frank Junker; Sabine Vogel-Ziebolz; Douglas Rex
Journal:  Mol Diagn Ther       Date:  2011-06-01       Impact factor: 4.074

3.  Colorectal cancer screening in Canada: results from the first round of screening for five provincial programs.

Authors:  D Major; H Bryant; M Delaney; S Fekete; L Gentile; M Harrison; V Mai; E Nicholson; Y Taylor
Journal:  Curr Oncol       Date:  2013-10       Impact factor: 3.677

4.  Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland.

Authors:  J Pitkäniemi; K Seppä; M Hakama; O Malminiemi; T Palva; M-S Vuoristo; H Järvinen; H Paimela; P Pikkarainen; A Anttila; L Elovainio; T Hakulinen; S Karjalainen; L Pylkkänen; M Rautalahti; T Sarkeala; H Vertio; N Malila
Journal:  BMJ Open Gastroenterol       Date:  2015-06-08

5.  Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland.

Authors:  Linda Sharp; Lesley Tilson; Sophie Whyte; Alan O Ceilleachair; Cathal Walsh; Cara Usher; Paul Tappenden; James Chilcott; Anthony Staines; Michael Barry; Harry Comber
Journal:  BMC Health Serv Res       Date:  2013-03-19       Impact factor: 2.655

6.  Organised colorectal cancer screening in Lampang Province, Thailand: preliminary results from a pilot implementation programme.

Authors:  Thiravud Khuhaprema; Suleeporn Sangrajrang; Somkiat Lalitwongsa; Vanida Chokvanitphong; Tawarat Raunroadroong; Tawee Ratanachu-Ek; Richard Muwonge; Eric Lucas; Christopher Wild; Rengaswamy Sankaranarayanan
Journal:  BMJ Open       Date:  2014-01-15       Impact factor: 2.692

7.  Public stated preferences and predicted uptake for genome-based colorectal cancer screening.

Authors:  Catharina G M Groothuis-Oudshoorn; Jilles M Fermont; Janine A van Til; Maarten J Ijzerman
Journal:  BMC Med Inform Decis Mak       Date:  2014-03-19       Impact factor: 2.796

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.